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phy (MDCTA)Abstract Purpose: To evaluate the reliability of D-Dimer test results in the diagnosis of PE in
high risk patients.
Patients and methods: This prospective study was conducted on 98 patients. Mean age was 50 years;
age range was 17–88 years. All patients underwent D-Dimer assay. Multidetector CT Angiography
(MDCTA) was performed on 128 row multi-slice scanner. Statistical analysis of D-Dimer test values
was attempted to assess its diagnostic reliability. Patients were further stratified into two groups:
patientswith positiveD-Dimer test andpatientswith negativeD-Dimer test, and cut-off value patients
with negative D-Dimer test and cutoff value was estimated for D-Dimer test results.
Results: Statistical analysis of D-Dimer test values yielded sensitivity 100%, specificity 28% with
100%negative predictive value (NPP) and lowpositive predictive value (26%). Likelihood ratios were
NLR<0.1 and PLR<1. Cutoff value for D-Dimer test results in correlation with CT Angiography
results, was 1.45 lg/ml, with diagnostic sensitivity 87% and diagnostic specificity 57%. PLRwas 0.43
and NLR was 0.13.
Conclusion: Negative D-Dimer test is a reliable diagnostic modality to rule out the need for CT
Angiography in patients at high risk population of PE. However, positive test results cannot
confirm the diagnosis and further testing is warranted.
 2016 The Egyptian Society of Radiology and NuclearMedicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Pulmonary Embolism (PE) is a well known disease, considered
as one of two clinical presentations of the same pathology:
venous thromboembolism (VTE), and deep vein thrombosis
(DVT) (1). DVT affecting the legs accounts for about 90%
Table 1 High risk patient categories.
Patient category No. %
Oncology 57 37.5%
Surgery 56 36.8%
Cardiology 39 25.7%
Total 152 100
No. = number, % (percent).
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third cardiovascular emergency condition that follows myocar-
dial infarction and stroke (3). The importance of PE is attrib-
uted to being a preventable cause of death in hospitalized
patients (4). Moreover, it is rapidly fatal in 10% of cases.
Death occurs in about 5% of cases after the onset of treatment
and about one-third of the patients develop complications as
pulmonary hypertension (5).
Patients susceptible for PE include those with previous
VTE, oncology, recent surgery, prolonged bed rest, estrogen
therapy and old aged patients. Yet, 25% of PE are idiopathic
cases (4,6). The clinical probability of PE can be achieved by
combination of multiple variables. These variables include
clinical signs and symptoms, and laboratory tests together with
clinical scores (7): Wells score (8), Revised Geneva e (9) and
Miniati scores or Pisa score (10); of which the most widely
used is Wells score (11).
The most significant symptoms for diagnosis of acute PE
are as follows: sudden onset of dyspnea, chest pain and
fainting especially when associated with specific ECG and
chest X-ray findings (12). Other signs and symptoms include
haemoptysis, DVT, tachycardia and tachypnea with low oxy-
gen saturation (2). However, clinical diagnosis of PE remains
a clinical suspicion that requires further investigation (12).
Consequently, patients with high clinical probability based
on clinical pre-test, need confirmatory test while those with
low probability need exclusionary test (13,14).
The diagnosis of PE with ventilation/perfusion scintigraphy
is based on functional parameter changes, when perfusion
defect is detected in normally ventilated areas which is termed
ventilation/perfusion mismatch. Pulmonary CTA diagnosis of
PE is established through the direct detection of thrombus
within the affected vessel (3). Thus, ventilation–perfusion scan
is non-diagnostic in up to 70% of cases (15).
Catheter pulmonary angiography was considered the refer-
ence standard for diagnosis of PE; however, its use is limited
because it is an invasive diagnostic procedure (16). MDCT
Angiography is now the non-invasive diagnostic modality of
choice in patients not having history of renal failure or allergy
to contrast agents (17). However, because of the cost of CT
examination, exposure to radiation and contrast media, it
should be limited to cases only in need, in order to reduce
number of negative pulmonary angiograms (18).
Immunoturbidimetric assays are a new generation of rapid,
automated, quantitative D-Dimer tests based on agglutination
of microlatex particles which are coated with monoclonal anti-
bodies that are specific for D-Dimer (19). It is the primary
diagnostic test in cases of low to moderate clinical suspicion
(2). Plasma D-Dimer concentrations above 0.5 lg/ml have
95% sensitivity and 55% specificity for VTE (16).
Therefore, the aim of this study was to evaluate the reliabil-
ity of D-Dimer test results in the diagnosis of PE in high risk
patients without the need of further investigation by CT
Angiography.
2. Patients and methods
2.1. Patients
This prospective research was conducted in the period between
January 2014 and March 2015 for cases referred fromOncology, Cardiology and Surgery Departments. The study
was carried out on 98 patients referred with clinical probability
of Pulmonary Embolism (PE), from which informed consent
was waived. They were classified into 3 groups of high risk
patients (Table 1): 39 patients (39.8%) with history of malig-
nant tumor, 36 patients (36.7%) had recent surgery, and 23
patients (23.5%) were being treated for cardiac disease. Mean
age was 50 years; age range was 17–88 years. 55 were males
(56%) and 43 were females (43.9%).
2.2. Inclusion criteria
Referral based on clinical examination with symptoms and
signs suggestive of pulmonary embolism and/or history of
DVT or PE. 98 patients underwent D-Dimer assay preceding
or following CTA within the range of 24 h, and positive
D-Dimer threshold was greater than 0.5 lg/ml.
2.3. Exclusion criteria
High risk cases who performed CT Angiography but did not
perform D-Dimer test for whom the referring clinician
assumed false positive D-Dimer because of repeated
catheterization and hemodynamic instability. Also, patients
with history of contrast medium allergy, renal failure or
intravenous line inaccessibility for whom CT Angiography
was contraindicated.
2.4. Methods
Multidetector Pulmonary CT Angiography (MDCTA) was
performed on a Multidetector CT scanner (128 row multi-
slice volume scanner, Philips Healthcare, Best, Netherlands)
with 0.8-s helical rotation speed, 1.25-mm collimation, and a
pitch of 3:1. Patients were injected with 100 mL of iopamidol
diluted with saline chaser dose to 120 mL total volume at a
rate of 3 mL/s using automated bolus-triggering technique.
Imaging began 20 s after initiation of contrast infusion.
2.5. D-Dimer assay
D-Dimer assay was done by using STA Liatest kit
(Diagnostica Stago, Asnieres, France). Blood for D-Dimer
assay was collected in 0.109 mol/L (3.2%) trisodium citrate
anticoagulant according to the standards of National
Committee for Clinical Laboratory guidelines. Samples were
centrifuged for 15 min at 2500 g. Processing and analysis of
samples were done within 1–2 h of collection by using
STA-R coagulation analyzer (Diagnostica Stago). This
Table 3 Statistical analysis of D-Dimer assay results.
Value %
Sensitivity 1 100%
Specificity 0.282 28%
PPV 0.263 26%
NPV 1 100%
PLL 0.718
NLL <0.1
PPV= positive predictive value, NPV= negative predictive value,
PLL = Likelihood ratio.
NLL= Negative likelihood ratio. % (percent).
Table 4 Statistical analysis of D-Dimer test results at cutoff
value 1.45 lg/ml.
Value %
Sensitivity 0.87 87%
Specificity 0.57 57%
PLL 0.43
NLL 0.13
PPV= positive predictive value, NPV= negative predictive value,
PLL = Likelihood ratio.
NLL= Negative likelihood ratio. % (percent).
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tative assessment of D-Dimer in plasma. The results were
expressed as micrograms for each milliliter D-Dimer unit
(DDU). D-Dimer value less than 0.5 lg/ml DDU was
interpreted as normal value, and D-Dimer value greater than
or equal to 0.5 lg/ml DDU was interpreted as positive
D-Dimer test.
3. Statistical analysis
Statistical analysis was performed by using the program Statis-
tical Package for the Social Sciences (SPSS) Version 20.0 for
Windows. Statistical analysis of D-Dimer test values was
attempted to assess its diagnostic reliability. Specificity, sensi-
tivity, positive and negative predictive values and likelihood
ratios were estimated. Patients were further stratified into
two groups: patients with positive D-Dimer test and patients
with negative D-Dimer test. Continuous variables were com-
pared using the Student’s t-test and cutoff value was estimated
for D-Dimer test results.
4. Results
A total of 98 patients included in our study were evaluated for
pulmonary embolism using CT Angiography as the gold stan-
dard test; 20 of which (20.4%) were diagnosed as positive PE
and 78 (79.6%) were negative. D-Dimer assay results were 76
(77.55%) diagnosed as positive and 22 (22.44%) were negative
for PE (Table 2).
Statistical analysis of D-Dimer test values yielded sensitiv-
ity 100%, specificity 28% with 100% negative predictive value
(NPP) and low positive predictive value (26%). Likelihood
ratios demonstrate that D-Dimer test is reliable to rule out
the need for CTA (NLR <0.1); however, the likelihood of
positive CT Angiography when D-Dimer assay is positive is
very low (PLR <1) (Table 3).
Cutoff value for D-Dimer test results in correlation with
CT Angiography results, was 1.45 lg/ml., with diagnostic sen-
sitivity 87% and higher diagnostic specificity 57%. Yet, at this
value positive likelihood ratio was 0.43 which still means that
positive D-Dimer test has a poor likelihood of positive CT
Angiography. Meanwhile negative likelihood ratio was 0.13,
confirming the strong negative predictive value of D-Dimer
test Table 4.
5. Discussion
CTA is now recognized as the diagnostic modality of choice to
establish the diagnosis of PE (20). CT outstands any other
imaging modality by its capability of detecting abnormalityTable 2 D-Dimer assay and MDCTA results.
D-Dimer test No. CTA Result for PE
(+ve) (ve)
Positive 76 20 56
Negative 22 0 22
Total 98 20 78
No. = number, % (percent), (+ve) = positive, (ve) = negative.in both mediastinum and pulmonary parenchyma (21,22). This
is because a variety of serious conditions have been detected in
patients clinically at-risk of PE, for example, pneumothorax
and aortic dissection (23,24).
With the advent of MDCT, strategies have been adopted to
achieve optimal vascular enhancement; for example the use of
a bolus test dose or automated bolus triggering technique (25),
which we implemented in our study. Single breath-hold scan-
ning significantly decreases respiratory motion artifacts in dys-
pneic patients (26). Similarly, reduced temporal resolution and
ECG gating eliminated or significantly decreased artifacts
from cardiac pulsation (27,28). This explains the reason for
CT being overwhelmingly the diagnostic modality of choice
for diagnosis of PE.
The diagnosis of pulmonary embolism was confidently
diagnosed by Multidetector CT Angiography (MDCTA) that
was carried out for 98 patients included in our study; 20 cases
(20.4%) were diagnosed as positive PE. The location of throm-
bus in the main pulmonary artery, lobar, segmental and sub-
segmental pulmonary artery branches was precisely reported
(Figs. 1–3) as well as of intracardiac (Fig. 2d) and IVC
thrombosis (Fig. 3d), in addition to associated parenchymal
findings such as pulmonary consolidation and pleural effusion
(Figs. 1–3) and right ventricular dysfunction with subsequent
flattening of interventricular septum and contrast reflux into
the IVC and hepatic veins (Fig. 2e and f).
In our study cohort, 76 cases (77.55%) were diagnosed as
negative on MDCTA evaluation and received no treatment
for PE. Anticoagulant therapy can be safely stopped after neg-
ative CT Angiography for PE, as only 1 % of cases were
reported in the literature to have recurrent thrombo-
embolism within the next three months (29,30).
All negative cases for PE on MDCTA yielded negative
D-Dimer test (Table 2); consequently, D-Dimer test results
Fig. 1 Male patient, 66 years old, with history of esophageal carcinoma; presented with cardiac arrest. After ICU admission and
stabilization, she was referred for MDCTA. Findings: Axial (a) and coronal (b) images show the following: Filling defects are seen inside
the main left and distal right pulmonary arteries extending into the lower lobe branches, denoting PE. Axial (c) image shows associated left
lower lobe consolidation and mild bilateral pleural effusion.
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(NPV) on statistical analysis (Table 3). This was also reported
by a similar study conducted on oncologic patients (31),
reporting NPV and sensitivity as 97% and 98%, respectively;
and in agreement with another study (32), which suggested
that it is possible to avoid unnecessary MDCTA by clinical
correlation with D-Dimer test results.
On the contrary, 56 out of 76 high risk cases that were diag-
nosed as positive D-Dimer assay were diagnosed as negative
for PE on MDCTA (Table 2), resulting in low specificity and
positive predictive value, 28% and 26%, respectively (Table 3).
In an attempt to calculate the diagnostic reliability of positive
D-Dimer test, we estimated the cutoff value of the test results
(1.45 lg/ml); however, the increase in specificity was not satis-
factory to rely on positive results to establish the diagnosis, as
positive likelihood ratio was 0.43 (Table 4). This means
that increasing the threshold of positive test result to higher
than the standard value (0.5 lg/ml) still yields false positive
results.Therefore, we can deduce that our findings are in agreement
with previous studies which stated that D-Dimer test is not
reliable in cases with high clinical probability (18,33,34).
Based on the results of this study, negative D-Dimer assay
in high risk patients can only rule out the necessity of further
testing for PE. Yet, positive D-Dimer assay, even with higher
thresholds for positive results, can neither confirm nor exclude
the possibility of PE and further testing is required. Unless
contraindicated, MDCTA is the imaging modality of choice
for diagnosis of PE and once confirmed, anticoagulant therapy
should be started. Our recommendation is concordant with
that of previously published international recommendations
as the primary diagnostic modality of choice in patients with
a positive D-Dimer or high clinical susceptibility (1,35).
Our results could be limited by selection bias followed in
our methodology where cases were confined to high risk group
of patients only. Another limitation of the current study is the
relative small number of patients lacking a broad range of
statistical confirmation.
Fig. 2 Female patient, 55 years old, presented with cardiogenic shock. After ICU admission and tracheostomy, she was referred for
MDCTA. Findings: Axial (a), coronal (b) sagittal oblique (c) images show the following: acute thrombus is impacted in the distal end of
the main pulmonary artery, and scattered thrombi are seen within the left lower lobe posterior segmental and lingular subsegmental
branches. Axial (d) shows the following: significant dilatation of the right atrium with intra-atrial filling defect (1.5 cm) in diameter
representing a thrombus (arrow); associated left basal small atelectasis is noted. Axial (e and f) show the following: right sided cardiac
dysfunction is demonstrated in the form of flattening of the interventricular septum (arrow in e) and reflux of CM into the IVC with
dilated hepatic veins (f).
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Fig. 3 Female patient, 76 years old presented with sudden chest pain and dyspnea with decreased oxygen saturation. She had a history
of malignant gastric neoplasm. Findings: Axial (a and b) and sagittal oblique (c) show the following: filling defects in the main pulmonary
arteries and distal segmental branches. Axial (d) shows: filling defect in the intrahepatic portion of the IVC denoting its thrombosis
(arrow). There is associated bilateral basal pleural reaction and right basal segmental consolidation.
506 S.E. Taman et al.In conclusion, MDCTA is the primary modality of choice
for diagnosis of PE; yet, the request for CT examination should
be in correlation with clinical probability and D-Dimer test
results. Negative D-Dimer test is a reliable diagnostic modality
to rule out the need for CT Angiography in patients at high risk
population of PE. However, positive test results cannot confirm
the diagnosis and further testing is warranted.
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